Proteinuria as a Noninvasive Marker for Renal Allograft Histology and Failure: An Observational Cohort Study

Abstract

Proteinuria is routinelymeasured to assess renal allograft status, but the diagnostic and prognostic values of this measurement for renal transplant pathology and outcome remain unclear. We included 1518 renal allograft recipients in this prospective, observational cohort study. All renal allograft biopsy samples with concomitant data on 24-hour proteinuria were included in the analyses (n=2274). Patients were followed for $7 years posttransplantation. Compared with proteinuria ,0.3 g/24 h, the hazard ratios for graft failure were 1.14 (95% confidence interval [95% CI], 0.81 to 1.60; P=0.50), for proteinuria 0.31.0 g/24 h, 2.17 (95% CI, 1.49 to 3.18; P<0.001), for proteinuria 1.03.0 g/24 h, and 3.01 (95% CI, 1.75 to 5.18; P<0.001), for proteinuria .3.0 g/24 h, independent ofGFRand allograft histology. The predictive performance of proteinuria forgraft failurewas lower at 3months after transplant (area under the receiver-operating characteristic curve [AUC] 0.64, P<0.001) than at 1, 2, and 5 years after transplant (AUC0.73, 0.71, and 0.77, respectively, all P<0.001). Independent determinants of proteinuria were repeat transplantation, mean arterial pressure, transplant glomerulopathy, microcirculation inflammation, and de novo/recurrent glomerular disease. The discriminatory power of proteinuria for these intragraft injury processes was better in biopsy samples obtained .3 months after transplant (AUC 0.73, P<0.001) than in those obtained earlier (AUC 0.56, P,0.01), with 85% specificity but lower sensitivity (47.8%) for proteinuria.1.0 g/24 h. These data support current clinical guidelines to routinelymeasure proteinuria after transplant, but illustrate the need for more sensitive biomarkers of allograft injury and prognosis.